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Abstract
Background: Autotaxin (ATX) possesses lysophospholipase D (lyso PLD) activity, which converts
lysophosphatidylcholine (LPC) into lysophosphatidic acid (LPA). The ATX-LPA signaling axis has been implicated in
angiogenesis, chronic inflammation and tumor progression. Osteopontin (OPN) is an important chemokine
involved in the survival, proliferation, migration, invasion and metastasis of gastric cancer cells. The focus of the
present study was to investigate the relationship between the ATX-LPA axis and OPN.
Results: In comparison with non-treated cells, we found that the ATX-LPA axis up-regulated OPN expression by
1.92-fold in protein levels and 1.3-fold in mRNA levels. The ATX-LPA axis activates LPA2, Akt, ERK and ELK-1 and
also protects SGC7901 cells from apoptosis induced by Taxol treatment.
Conclusions: This study provides the first evidence that expression of OPN induced by ATX-LPA axis is mediated
by the activation of Akt and MAPK/ERK pathways through the LPA2 receptor. In addition, OPN is required for the
protective effects of ATX-LPA against Taxol-induced apoptosis and ATX-LPA-induced migration of SGC7901 cells.
Background
Autotaxin (ATX), also known as phosphodiesterase-I
alpha (PD-I alpha) or ecto-nucleotide pyrophosphatase/
phosphodiesterase 2 (NPP2 or ENPP2), is overexpressed
in various tumors, including gastric cancer, ovarian can-
cer [1], breast cancer [2]. ATX has lysophospholipase D
(lysoPLD) activity, which converts lysophosphatidylcho-
line (LPC) into lysophosphatidic acid (LPA) [3]. LPA
levels have been reported to be elevated in diverse phy-
siological and pathological conditions including preg-
nancy, high cholesterol diet, and ovarian cancer [4]. The
biological outcome of ATX activity depends on the local
availability of its substrate LPC [5]. The ATX-LPA sig-
naling axis has been implicated in angiogenesis, chronic
inflammation, fibrotic diseases and tumor progression,
making this system an attractive target for therapy [6].
LPA elicits a variety of cellular biological responses
through LPA receptors, which are a family of seven-
transmembrane G protein-coupled receptors (GPCRs),
including LPA1, LPA2, LPA3, and LPA4 [7]. LPA1-
LPA3 receptors are expressed in various combinations
in almost every tissue throughout the body, while LPA4
receptor is not widely expressed in human tissues [8].
LPA enhances the migration of gastric cancer cells by
mediating the location of RhoA [9].
Osteopontin (OPN), a glycophosphoprotein cytokine,
plays an important role in both physiological and patho-
logical processes, such as cell adhesion, chemotaxis, pro-
tection of apoptosis, invasion and migration [10]. Recent
studies have demonstrated that OPN is highly expressed
in gastric cancer tissues compared to their surrounding
gastric mucosa tissues [11]. In this study, we investi-
gated the relationship between ATX-LPA axis and OPN
in the human gastric cancer cell line, SGC7901 cells.
Results
LPA and ATX/LPC induced OPN expression in SGC7901
cells
We first investigated the relationship between OPN and
the ATX-LPA axis by examining the expression of OPN
in SGC7901 cells treated with or without ATX, LPC,
LPA, and ATX/LPC. Figure 1A shows a time course of
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μM) (ATX/LPC2) and a better time point of 24 hours.
We found that LPA, ATX/LPC1 and ATX/LPC2
induced an increase in OPN expression in both protein
(Figure 1C) and mRNA (Figure 1B) levels. However,
ATX or LPC alone did not induce significant changes in
OPN expression, suggesting that the increased OPN
expression was induced by LPA, which was converted
by ATX and LPC. Compared to non-treated cells, OPN
expression induced by LPA, ATX/LPC1 and ATX/LPC2
was 1.58-fold, 1.63-fold and 1.92-fold, respectively in
protein levels (Figure 1C); and 1.3-fold in mRNA levels
(Figure 1B) (P < 0.05).
ATX/LPC-regulated OPN expression was mediated by
LPA2 receptor and activation of Akt and MAPK/ERK
To determine whether the LPA receptor is responsible
for LPA signal transduction, SGC7901 cells were treated
with ATX, LPC, LPA, ATX/LPC2 for 18 hours, and the
expression of LPA receptors was detected by real time-
PCR. Our results suggest that the expression of LPA1,
LPA2, LPA3 and LPA4 receptors were all found in
SGC7901 cells. However, the expression of the LPA2
receptor was increased upon treatment with ATX/LPC2,
suggesting that the LPA2 receptor might be the predo-
minant receptor mediating LPA-induced OPN expres-
sion in SGC7901 cells (Figure 2A-D).
To further explore the mechanisms underlying LPA-
induced OPN expression, we focused on the mitogen
activated protein kinase (MAPK) and Akt signaling
pathways. SGC7901 cells were treated with the reagents
described above for 30 min, and total protein was
extracted by Western blot to detect phosphorylation of
either ERK or Akt. Total ERK and Akt levels were
assessed as controls. We found that LPA and ATX/
LPC2 induced both ERK and Akt phosphorylation in
SGC7901 cells (Figure 2E). We treated SGC7901 cells
with ATX/LPC2 in the presence of various inhibitors
including the LPA receptor inhibitor, Ki16425; ERK
inhibitor, PD98059; and PI3kinase inhibitor, LY294002
to examine the involvement of the LPA receptor, Akt
and ERK in LPA or ATX/LPC2-induced OPN expres-
sion. Our results indicated that ATX/LPC-induced OPN
expression in SGC7901 cells was largely reduced by the
previously mentioned inhibitors (Figure 2F and 2G),
suggesting that ATX/LPC-induced OPN expression is
mediated by the LPA2 receptor as well as the activation
of ERK and Akt.
Determination of Elk-1 activities in SGC7901 cells
Transfection of SGC7901 cells with either the pFR-Luc
plasmid (reporter plasmid), or the pFA2-Elk1 plasmid
(fusion trans-activator plasmid) allowed us to gain a bet-
ter understanding of the ATX-OPN signaling pathways.
Figure 1 LPA and ATX/LPC induce OPN expression in SGC7901 cells. (A) Time course of OPN stimulation utilizing ATX (50 ng/ml) + LPC (20
μM) (ATX/LPC2). OPN expression was examined in SGC7901 cells by Western blot and real time-PCR. SGC7901 cells were treated with ATX, LPC,
LPA, ATX/LPC1, ATX/LPC2 or DMEM/0.1% BSA. Total protein and RNA was extracted for Western blot (C) and real time -PCR (B), respectively.
Figure1 D showed the densitometric ratio of OPN protein/a-tubulin. Statistical analysis was performed using Student’s t test. *p < 0.05. The ATX/
LPC concentration curve [4] for stimulated motility provides a justification for the concentrations of ATX/LPC chosen throughout the manuscript.
LPA or ATX/LPC stimulates OPN production in additional cell lines (eg, SMMC7721 in our study: ATX-LPA axis induces expression of OPN in
hepatic cancer cell SMMC7721) as well as in SGC7901 cells.
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Ki16425, PD98059, and LY294002. Luciferase activity of
pFA2-Elk1stimulated by ATX/LPC2 was approximately
2.7 folds higher compared with that of the non-treated
control cells. Nevertheless, in the presence of Ki16425,
PD98059, or LY294002, the pFA2-Elk1 activities induced
by ATX/LPC2 were reduced by 1.67-fold, 1.87-fold and
1.79-fold, respectively (Figure 3). These reductions
showed convincing evidence that the LPA receptor,
ERK, and Akt were partially required in these processes.
Requirement of OPN in migration induced by the ATX-
LPA axis protected against Taxol-induced apoptosis in
SGC7901 cells
We established OPN-deficient SGC7901 cell lines
through the introduction of OPN siRNA (clone1, clone2,
clone3) to better understand the role of OPN in the
ATX-LPA axis. SGC7901-vehicle was used as control.
OPN expression was significantly down-regulated in
clone3, which was then used in our study (Figure 4A).
A transwell-migration assay was performed to further
investigate the biological functions of OPN knockdown
in SGC7901 cells, and to detect LPA-induced migration
in SGC7901-siRNA-OPN cells. LPA and ATX/LPC2 sig-
nificantly promoted migrations of SGC7901 cells from
either 169 cells to 596 cells (LPA) or to 670 cells (ATX/
LPC2); from either 135 cells to 473 cells (LPA) or to
369 cells (ATX/LPC2) in SGC7901-siRNA-neg cells;
however, no significant effect was found on the migra-
tions of SGC7901-siRNA-OPN cells, from either 111
cells to 130 cells (LPA) or to 116 cells (ATX/LPC2)
(Figure 4B, C), suggesting that OPN is required in the
Figure 2 ATX/LPC-regulated OPN expression is mediated by LPA2 receptor and activation of Akt and MAPK/ERK. SGC7901 cells were
exposed to ATX, LPC, LPA, ATX/LPC2 or DMEM/0.1% BSA for 24 hours or 30 min, and then total RNA and protein were extracted for real time-
PCR (A-D) and Western blot (E, F), respectively. (E) Immunoblotting was performed to detect the phosphorylation status of ERK and Akt. Total
ERK and Akt levels were assessed as control. (F) The effects of the LPA inhibitor, ERK inhibitor and Akt inhibitor on ATX/LPC2-induced OPN
expression in SGC7901 cells. SGC7901 cells were treated with Ki16425, PD98059, LY294002 or DMSO (0.1%; a solvent control) for 45 min prior to
ATX/LPC2 treatment. 24 hours following stimulations, OPN expression was measured by Western blot analysis. All experiments were performed
in triplicate and a representative result is shown here. Figure 2G showed the densitometric ratio of OPN protein/a-tubulin. Statistical analysis was
performed using Student’s t test. *p < 0.05.
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LPC.
ATX has been reported to protect Taxol-induced
apoptosis in MCF-7 breast cancer cells and MDA-MB-
435 melanoma cells [12]. We investigated whether the
ATX-LPA axis also protected against Taxol-induced
apoptosis in SGC7901 cells. Using flow cytometry, we
found that treatment of SGC7901 cells with 50 nM
Taxol resulted in a 64% increase in apoptosis. In com-
paring with the controls, either LPA alone, or ATX/
LPC2 inhibited Taxol-induced apoptosis to 23.4% (LPA)
or 21% (ATX/LPC2) in SGC7901 cells. Interestingly, in
SGC7901-siRNA-OPN cells (clone3), LPA or ATX/
LPC2 inhibited Taxol-induced apoptosis to 37% (LPA)
or 37.7% (ATX/LPC2) (Figure 4D and 4E). The protec-
tive effect of LPA decreased to 58.1%. These results sug-
gested that OPN is required in each of the processes
and either LPA or ATX/LPC had a significant protective
effect against Taxol-induced apoptosis.
Discussion
Gastric cancer is the fourth most common cancer in
developing countries, including China [13]. Many mole-
cular events are responsible for the initiation of gastric
cancer and its progression. ATX, an extracellular
lysoPLD, that catalyzes the conversion from LPC to
LPA, exerts various biological effects through the lipid-
signaling molecule, LPA [14,15]. OPN was shown to be
frequently overexpressed in many human cancers,
including lung cancer [16], colorectal cancer [17] and
stomach cancer. OPN has been demonstrated to pro-
mote the survival of gastric cancer SGC7901 cells in the
condition of cellular stresses induced by serum withdra-
wal or curcumin treatment [11]. Although several lines
of evidence have suggested that the ATX-LPA axis and
OPN can be used as tumor markers, the relationship
between ATX and OPN is still not clear. In this study,
we observed that LPA, ATX/LPC induced OPN expres-
sion (Figure 1), and OPN were required for the effect of
t h eA T X - L P Aa x i so nt h eh u m a ng a s t r i cc a n c e r
SGC7901 cells.
ATX, LPA, and OPN elicit a wide range of cellular
responses, including cell proliferation and migration
[11,5]. Taxol, known as paclitaxel, is a very important
drug to promote apoptosis [12]. In our present study,
Figure 4D showed that LPA and ATX/LPC was required
in the protection against Taxol-induced apoptosis in
SGC7901 cells. LPA and ATX/LPC also significantly
promoted the migration of SGC7901 cells, but had no
significant effects on the migration of OPN-deficient
SGC7901 cells (Figure 4B, C), suggesting that OPN was
indispensable for ATX/LPC-induced migration and
OPN was required in the protective effect against
Taxol-induced apoptosis in SGC7901 cells. It is likely
that ATX generates LPA from LPC and then LPA dis-
plays protective effect on these cells, which requires
further studies.
LPA mediates its activity through a series of G pro-
tein-coupled receptors [18]. Many gastric cancer cell
lines have been shown to express at least one LPA
receptor [19]. In our study, expression of the LPA2
receptor was up-regulated by ATX/LPC2 (Figure 2A-D),
consistent with previous results that ovarian cancers
showed markedly increased expression of LPA2 recep-
tors [20]. Although Ki16425 (inhibitor of LPA receptors)
is somewhat LPA-receptor specific with the order of
inhibition of LPA1 > LPA3 >> LPA2, data from our
experiment revealed that LPA2 possibly played more
important roles in the process of ATX/LPC2- induced
expression of OPN.
The extracellular signal-regulated kinase/mitogen-acti-
vated protein kinase (ERK-MAPK) and PI3K/Akt signal-
ing pathways are evolutionarily conserved kinase
modules that link extracellular signals to the machinery
controlled fundamental cellular processes such as
growth, proliferation, differentiation, migration and
apoptosis; all are critical in human malignancies. In our
study, phosphorylation of ERK and Akt were upregu-
lated by ATX/LPC and LPA, and down-regulated by
their inhibitors, PD98059 and LY294002. Our data
clearly indicated that LPA-induced overexpression of
OPN was mediated by either PI3K/Akt or ERK signaling
Figure 3 Determination of Elk-1 activities in SGC7901 cells.
SGC7901 cells were transfected with either the pFR-Luc plasmid
(reporter plasmid), or the pFA2-Elk1 plasmid (fusion trans-activator
plasmid). Cells were then treated with ATX/LPC2, in the absence or
presence of DMSO, Ki16425, PD98059, LY294002, harvested and the
luciferase activity was measured. Statistical analysis was performed
using Student’s t test. *p < 0.05.
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Page 4 of 8Figure 4 Requirement of OPN in migration induced by ATX-LPA axis protects against Taxol-induced apoptosis in SGC7901 cells.( A )
Verification of siRNA knockdown of the OPN protein by Western blot showed a significant reduction of OPN protein in clone3 (SGC7901-siRNA-
OPN). (B) The effect of OPN on ATX-LPA-induced migration was assayed using a Transwell assay. Either SGC7901, SGC7901-siRNA-vehicle, or
SGC7901-siRNA-OPN cells (1 × 10
5) were added in the upper chambers of the transwells, incubated in DMEM/0.1% BSA or medium containing
ATX, LPC, LPA, ATX/LPC2 and allowed to migrate for 48 hours at 37°C. Migrated cells on the lower chamber were quantified. (D) Flow cytometric
analysis of apoptosis: SGC7901, SGC7901-siRNA-vehicle, or SGC7901-siRNA-OPN cells were treated with Taxol (50 nM) in the absence or presence
of each group: ATX, LPC, LPA, ATX/LPC2 or DMEM/0.1% BSA for 24 hours. Apoptosis was analyzed by flow cytometry. Data shown in Figure 4C
and E represents the mean ± SD from three individual experiments. Data are mean ± SD of triplicate determinations. Statistical analysis was
performed using Student’s t test. *p < 0.05.
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related to cell proliferation and survival such as Elk-1.
As a major substrate of the MAPK family, Elk-1 plays a
key role in cell differentiation, proliferation, tumorigen-
esis and apoptosis. Phosphorylation of Elk-1 appears to
be critical for the activation of c-fos transcription [21].
Our results proposed that Elk-1 connected the intracel-
lular signaling cascade of ATX-LPA2-OPN (Figure 3).
Conclusions
Our overall results provided novel evidence that the
ATX-LPA axis induces OPN expression via Akt and
MAPK/ERK-mediated mechanisms, and OPN is
required in migration induced by ATX-LPA axis, which
protects against Taxol-induced apoptosis in SGC7901
cells.
Methods
Reagents
ATX (recombinant human ENPP-2/Autotaxin) and
OPN antibody were purchased from R&D Systems
(Minneapolis, MN, USA). Oleoyl-L-a-lysophosphatidic
acid sodium salt (LPA), oleoyl-L-a-LPC, blasticidin,
MAPK inhibitor (PD98059), PI3K inhibitor (LY294002),
LPA receptor antagonist (Ki16425) and a-tubulin anti-
body (#T5168) were purchased from Sigma-Aldrich
(Saint Louis, MO, USA). Monoclonal anti-p44/42 MAP
kinase, anti-Phospho-p44/42 MAPK (Thr204/Tyr202),
total-Akt and phospho-Akt (Ser473) antibodies were
purchased from Cell Signaling Technology (Danvers,
MA, USA). pFR-Luc plasmid and pFA2-Elk1 plasmid
were purchased from Invitrogen (Carlsbad, CA, USA).
Cell culture
Human gastric cancer SGC7901 cells were cultured in
DMEM supplemented with 10% fetal bovine serum
(FBS), penicillin (100 U/ml), streptomycin sulfate (100
μg/ml), and maintained at 37°C with 5% CO2 in a humi-
dified incubator.
Construction of OPN-siRNA expression plasmids
SiRNA against OPN was produced from Invitrogen
(Carlsbad, CA, USA). The sequences of the selected
region to be targeted by siRNA for OPN were:
SR54-1F:TGCTGAATTGACCTCAGAAGATGCAC
GTTTTGGCCACTGACTGACGTGCATCTTGAGG
TCAATT;
SR54-1R: CCTGAATTGACCTCAAGATGCACGT
CAGTCAGTGGCCAAAACGTGCAT
CTTCTGAGGTCAATTC;
SR54-2F: TGCTGTTAACTGGTATGGCACAGGTGG
TTTTGGCCACTGACTGACCACC
TGTGATACCAGTTAA;
SR54-2R: CCTGTTAACTGGTATCACAGGTGGT
CAGTCAGTGGCCAAAACCACCTGT
GCCATACCAGTTAAC;
SR54-3F: TGCTGAATCACATCGGAATGCTCATT
GTTTTGGCCACTGACTGACAATG
AGCACCGATGTGATT;
SR54-3R: CCTGAATCACATCGGTGCTCATTGT-
CAG TCAGTGGCCAAAACAATGAG
CATTCCGATGTGATTC.
We used lipofectamine 2000 (Invitrogen, Carlsbad,
CA, USA) to separately transfect three types of OPN
constructs into SGC7901 cells. To select resistant
colonies, 48 hours after transfection, cells were cul-
tured in selective medium containing 3 μg/ml blastici-
din (Sigma-Aldrich, Saint Louis, MO, USA).
Blasticidin-resistant cells were maintained in culture
medium supplemented with 3 μg/ml blasticidin for
further analysis.
Western blotting analysis
SGC7901 cells (1 × 10
6) were treated with ATX(50 ng/
ml), LPC(10 μM), LPA(10 μM), ATX(50 ng/ml)+LPC(10
μM)(ATX/LPC1) or ATX(50 ng/ml)+LPC(20 μM)
(ATX/LPC2) for 24 hours, and then cells were lysed in
RIPA buffer. Equal amounts of protein (60 μg) were
electrophoresed on 12% SDS-PAGE gels and electro-
phoretically transferred to Immobilon-P membranes
(Millipore, Bedford, MA, USA). Membranes were incu-
bated overnight at 4°C with anti-OPN (1:100) or mono-
clonal anti-a-tubulin (1:5000) in TBST containing 1%
BSA (w/v). The membranes were incubated for 2 hours
with anti-rabbit or anti-mouse secondary antibodies, and
the immune complex was detected using an ECL plus
detection kit (Pierce, Rockford, IL, USA). The optical
densities of each band and the density ratio of OPN to
a-tubulin bands were calculated using a densitometer
(Furi, Shanghai, China).
Migration assay
Cell migration was performed using 24-well transwell
migration plates (Corning Costar, Schiphol-Rijk, Nether-
land). The upper chamber was filled with 100 μl of cell
suspension (1 × 10
5 cells) in DMEM/0.1% BSA. The
lower chamber contained 600 μl of the DMEM/0.1%
BSA with ATX (50 ng/ml), LPC (10 μM), LPA (10 μM),
ATX/LPC2. The filters were fixed with methanol and
stained with hematoxylin and eosin after 48h’si n c u b a -
tion. Cells remaining on the top side of the filter were
removed by soft mechanical scraping, and the number
of cells migrating to the bottom of the filter was
counted using a light microscope (in each chamber, six
fields were counted at 200× magnification for each
condition).
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Page 6 of 8RNA extraction and Real-Time PCR
Total RNA was extracted from SGC7901 cells incubated
in 6-cm plates after 18 hours of stimulation with either
ATX (50 ng/ml), LPA (10 μM), LPC (10 μM), ATX/
LPC1, ATX/LPC2, or DMEM/0.1% BSA alone as a
negative control, using Trizol (Invitrogen, Carlsbad, CA,
USA) according to the manufacturer’s instruction.
Reverse transcription was performed using a Rever-
tAidTM First Stand cDNA Synthesis Kit (MBI-Fermen-
tas). The transcript levels for OPN, LPA1, LPA2, LPA3,
LPA4 and b-actin were quantified by real-time PCR.
The primers used were as follows:
b-actin-F: 5-TCACCAACTGGGACGACAT-3
b-actin-R: 5-GCACAGCCTGGATAGCAAC-3
OPN-F: 5-AGGCTGATTCTGGAAGTTCTG-3
OPN-R: 5-GCTTTCGTTGGACTTACTTGG-3
LPA1-F: 5-GGTGATGGGACTTGGAAT-3,
LPA1-R: 5-AAACCGTAATGTGCCTCT-3;
LPA2-F: 5-TGGCTCAACCCAACCAAC-3,
LPA2-R: 5-CCTCATTACCCAGTCATACCG-3;
LPA3-F: 5-TGCTTCCCTCACCAACTT-3,
LPA3-R: 5-CCGCAGGTACACCACAAC-3;
LPA4-F: 5-AGTTGTTGGGTTTATCATTC-3,
LPA4-R: 5-AAACAGGGACTCCAT TCT-3 [22];
Flow cytometric analysis for apoptosis
SGC7901 cells were stimulated with the following treat-
ments: Taxol (50 nM), or Taxol (50 nM) containing
ATX (50 ng/ml), LPC (10 μM), LPA (10 μM), ATX/
LPC2 for 24 hours. Cultured cells were collected with
trypsin/EDTA and washed with PBS and stained with
Propidium Iodide (PI) or FITC-conjugated antibodies.
Fluorescence was quantified on 10,000 cells with Facs-
Calibur with Cellquest software (BD Biosciences,
PharMingen)
Luciferase (LUC) reporter assay
SGC7901 cells (1 × 10
5) were transfected with pFR-Luc
plasmid (reporter plasmid), or pFA2-Elk1 plasmid (fusion
trans-activator plasmid). Six hours later, the cells were
treated with the following drugs: ATX/LPC2, or ATX/
LPC2 containing DMSO, Ki16425 (15 μM), PD98059 (50
μM), or LY294002 (50 μM) and incubated for an addi-
tional 24 hours. The cells were then harvested and tested
using a Luciferase assay system (Promega, Madison, WI).
An error bar was established to show the SD derived
from three independent experiments.
Statistical analysis
Data were analyzed using a two-tailed Student’st - t e s t
for single comparisons and by one-way analysis of var-
iance for multiple group comparisons. Differences were
considered significant at * P < 0.05 versus control.
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